Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded at Zacks Research

Reckitt Benckiser Group (OTCMKTS:RBGLY) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday,Zacks.com reports.

Other equities analysts also recently issued reports about the company. Morgan Stanley upgraded Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a research report on Monday, March 16th. Kepler Capital Markets raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 17th. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy”.

Reckitt Benckiser Group Trading Up 0.3%

Shares of Reckitt Benckiser Group stock opened at $12.54 on Monday. Reckitt Benckiser Group has a fifty-two week low of $12.02 and a fifty-two week high of $17.80. The business’s fifty day moving average is $12.92 and its two-hundred day moving average is $14.90. The company has a debt-to-equity ratio of 0.98, a current ratio of 0.85 and a quick ratio of 0.63.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.